Superdisintegrants Market Worth $487.0 Million by 2025 | CAGR 7.2%: Grand View Research, Inc.

SAN FRANCISCO, August 15, 2017 /PRNewswire/ --

The global superdisintegrants market [http://www.grandviewresearch.com/industry-analysis/superdisintegrants-market ] is expected to reach USD 487.0 million by 2025, according to a new report by Grand View Research, Inc. Superdisintegrants help in the disintegration of tablet or capsule content into small particles and create a greater surface area for speedy drug release.

(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )

A number of fast disintegrating tablet such as salbutamol sulphate, and cetirizine hydrochloride in tablet/capsule dosage form for respiratory disorders (bronchitis, asthma, and coughing) are formulated for pediatric and geriatric patients, due to their difficulty or discomfort in swallowing. Superdisintegrant such as crospovidone, croscarmellose sodium, and sodium starch glycolate are used in optimized concentration to formulate such tablets/capsules along with different binders such as MCC and PVP K-30.

Browse full research report with TOC on "Superdisintegrants Market Analysis By Product (Croscarmellose sodium, Crospovidone, Sodium starch glycolate, Ion exchange resin), By Dosage Form (Tablets and Capsules, Mouth-dissolving Films), And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/superdisintegrants-market

Further key findings from the report suggest:

        
        - The market study suggests that crospovidone dominated the overall market in 2016.
          Crospovidone is completely insoluble in water and rapidly disperses and swells in
          water.   It has greatest rate of swelling and surface area to volume ratio compared to
          other disintegrants. Hence, these factors are contributing towards the large share of
          crospovidone in 2016.
        - Others segment, which includes natural superdisintegrants, is expected to witness
          highest growth rate. Factors such as local accessibility, bio-acceptable, renewable
          source, eco   friendly nature and lower prices compared to important synthetic products,
          are driving the growth of the segment during the forecast period.
        - Amongst the dosage form segments, tablets and capsules occupied the largest share in
          2016 as they are the most common and preferred dosage forms for delivering drugs to
          patients.
        - The mouth-dissolving films segment is expected to grow at the highest growth rate
          during the forecast period. It is the preferred choice for patients as compared to
          tablets and capsules due to greater flexibility and comfort of the former.
        - Hence, the market for disintegrants in mouth-dissolving films would continue to grow
          due to quicker onset of action for a dosage form and better convenience of
          administration.
        - North America dominated the regional segment with the largest revenue share in 2016,
          due to number of superdisintegrants manufacturers operating in the region and prolific
          research and development initiatives
        - Asia Pacific is expected to witness significant growth during the forecast period,
          owing to booming medical tourism industry in the region and lucrative contract
          research outsourcing services
        - Some of the major companies operating in this market are Ashland Global Holdings Inc.,
          Roquette Freres S.A., FMC Corporation, DFE Pharma, Huber Corporation, Nippon Soda Co.,
          Ltd. The Dow Chemical Company and BASF SE. and others.

Browse related reports by Grand View Research:

        
        - Kidney Cancer Drugs Market -
          http://www.grandviewresearch.com/industry-analysis/kidney-cancer-drugs-market
        - Biotechnology Reagents Market  -
          http://www.grandviewresearch.com/industry-analysis/biotechnology-reagent-market
        - ePharmacies Market -
          http://www.grandviewresearch.com/industry-analysis/epharmacies-market
        - Biopharmaceutical Market -
          http://www.grandviewresearch.com/industry-analysis/biopharmaceutical-market

Grand View Research has segmented the superdisintegrants market on the basis of product, dosage form, and region:

        
        - Product Outlook (Revenue, USD Million, 2014 - 2025)  
             - Croscarmellose sodium
             - Crospovidone
             - Sodium starch glycolate
             - Ion exchange resin
             - Others
        - Dosage Form Outlook (Revenue, USD Million, 2014 - 2025)  
             - Tablets and Capsules
             - Mouth-dissolving Films
        - Regional  Outlook (Revenue, USD Million, 2014 - 2025)  
             - North America
                - U.S.
                - Canada
             - Europe
                - Germany
                - UK
             - Asia Pacific
                - China
                - Japan
             - Latin America
                - Brazil
                - Mexico
             - MEA
                - South Africa

Read Our Blog By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

        

        Contact: 
        Sherry James 
        Corporate Sales Specialist, USA 
        Grand View Research, Inc 
        Phone: +1-415-349-0058 
        Toll Free: 1-888-202-9519 
        Email: sales@grandviewresearch.com 

Web: http://www.grandviewresearch.com

    Photo: 
    http://photos.prnewswire.com/prnh/20160524/371361LOGO

SOURCE Grand View Research, Inc.